Description:

SOUTHWEST ONCOLOGY GROUP S0227 TREATMENT FORM FOR FIRST CYCLE (S0227) S0227 Comparison of Cisplatin Combined With Either Paclitaxel or Gemcitabine in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9C3C405-9249-3D84-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9C3C405-9249-3D84-E034-0003BA12F5E7

Keywords:
Versions (2) ▾
  1. 12/18/14
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Cervical Cancer NCT00057928 Treatment - SOUTHWEST ONCOLOGY GROUP S0227 TREATMENT FORM FOR FIRST CYCLE (S0227) - 2057464v3.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP S0227 TREATMENT FORM FOR FIRST CYCLE (S0227)
    1. No Instruction available.
Header
Status
Vital Status
First Cycle Of Treatment
Were there any dose modifications or additions/omissions to protocol treatment
Concomitant Medications / Medical Interventions
Comments
Ccrr Module For Southwest Oncology Group S0227 Treatment Form For First Cycle (s0227)

Similar models